MCM
KZIA

MAI Capital Management’s Kazia Therapeutics KZIA Stock Holding History

MAI Capital Management’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-52
Closed -$375 – 4425
2025
Q3 		$375 Hold
52
– – ﹤0.01% 3653
2025
Q2 		$327 Sell
52
-719
-93% -$3.36K ﹤0.01% 3818
2025
Q1 		$3.02K Sell
771
-27,071
-97% -$160K ﹤0.01% 2870
2024
Q4 		$246K Buy
27,842
+564
+2% +$13K ﹤0.01% 1062
2024
Q3 		$586K Buy
+27,278
New +$544K 0.01% 697

Other funds holding KZIA

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MAI Capital Management's KZIA Position: Q4 2025 in Review

MAI Capital Management sold out of Kazia Therapeutics (KZIA) in Q4 2025, closing a stake of 52 shares — an estimated $375 sold.

MAI Capital Management first reported a position in KZIA in Q3 2024 and held it in 5 quarters. The position peaked at $586K in Q3 2024. 22 funds tracked by Wall St. Rank hold KZIA as of Q4 2025.

  • MAI Capital Management reported no remaining Kazia Therapeutics position as of Q4 2025 after selling out during the quarter.
  • MAI Capital Management sold 52 Kazia Therapeutics shares in Q4 2025, an estimated $375.
  • MAI Capital Management first reported a position in Kazia Therapeutics in Q3 2024 and held it in 5 quarters.
  • MAI Capital Management's Kazia Therapeutics position peaked at $586K in Q3 2024.
  • 22 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2025.

Based on MAI Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.